logo
No disruption in operations due to rare earth supply crisis: Maruti

No disruption in operations due to rare earth supply crisis: Maruti

Automaker says situation is 'uncertain and evolving' amid report that it has made e-Vitara production cuts
Deepak Patel New Delhi
Maruti Suzuki India (MSIL) said on Thursday its operations are unaffected by the global rare earth magnet shortage, but added that the situation is 'uncertain and evolving'.
The company said it is exploring multiple solutions to maintain continuity in operations and will notify stakeholders if any material impact arises.
The clarification comes amid a Reuters report earlier this week stating that the country's largest carmaker has slashed production estimates for its upcoming electric SUV, the e-Vitara, by nearly two-thirds due to rare earth supply constraints.
According to the report, MSIL has revised its production target for the e-Vitara from 26,000 units to just 8,200 units for the first half of FY26.
The report, citing internal documents, attributed the change to 'supply constraints' of critical rare earth elements, particularly magnets used in electric powertrains. Despite the scale back, MSIL reportedly aims to meet its full-year target of 67,000 units by ramping up production in the second half of the financial year.
'Regarding the situation on rare earth, as of now there is no disruption in our operation due to this issue,' said a MSIL spokesperson, in a statement on Thursday.
'There is a lot of uncertainty and the situation is continuously evolving. We are monitoring the situation and pursuing multiple solutions to ensure continuity in our operations. If and when there is any material impact to our business, we will inform all stakeholders in line with regulatory requirements,' the spokesperson added.
Rare earth magnets are a crucial component in electric vehicle (EV) motors and are also used in power steering systems, speakers, and other car components.
Their shortage stems from China's decision in April to tighten export controls on key rare earth elements, including neodymium, dysprosium and terbium. These elements are essential in the production of permanent magnets used in EVs.
According to the Federation of Automobile Dealers Associations (FADA), electric car sales in India reached 107,645 units in fiscal year 2024–25, up from 91,506 units in FY24, marking a 17.7 per cent year-over-year increase.
China controls more than 90 per cent of the global rare earth magnet supply chain. China's new export rules require companies to obtain end-use certifications and licences, which has slowed shipments and created uncertainty for automakers worldwide.
The disruption has raised alarm in India's automotive industry, especially among EV manufacturers who depend heavily on Chinese supplies.
The Indian government is monitoring the situation. A delegation may soon travel to China to expedite clearances for shipments stuck due to regulatory bottlenecks.
Additionally, the government is evaluating measures such as incentivising domestic rare earth magnet production and expanding recycling initiatives.
The rare earth crunch comes at a time when Indian automakers are stepping up EV production to meet future emission targets and global demand.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Iran-Israel war: Iran airspace shut, international flights from India to take longer
Iran-Israel war: Iran airspace shut, international flights from India to take longer

Time of India

time37 minutes ago

  • Time of India

Iran-Israel war: Iran airspace shut, international flights from India to take longer

Representative image NEW DELHI: Flights between the West and India, mainly Delhi and Mumbai, will get even longer following the Iranian airspace closure on Friday after Israel attacked the country's nuclear sites. Sixteen Air India (AI) flights were impacted Friday, with the majority diverting and the others returning to origin. AI had resumed overflying Iran shortly after Pakistan had closed its airspace to Indian carriers on April 24 to partially mitigate the longer route its flights had to take since then. While AI will have to take longer routes to and from the West, IndiGo between Delhi and Tbilisi and Delhi and Baku will become one-stop flights now. With both Pakistan and Iran no-go areas, Indian carriers will have to take really longer routes to reach Central Asia. "We are studying the situation and some AI flights may become one-stop after closure of Iran airspace," said sources. Also, if and when Iran retaliates, the airspace of countries near Israel, like Jordan and Lebanon, also be impacted. This has in the past forced airlines to take longer detours in that area whenever conflict escalates. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List "Due to the emerging situation in Iran, subsequent closure of its airspace, and in view of safety of our passengers, (some) Air India flights are either being diverted or returning to their origin. We regret the inconvenience caused to our passengers due to this unforeseen disruption and are making every effort to minimise it, including providing accommodation for passengers," Air India said Friday. "Refund on cancellation or complimentary rescheduling is also being offered to guests who opt for it. Alternative arrangements are being made to fly passengers to their destinations. We advise passengers to check their flight status," AI added. Air India flights impacted Friday were AI-130 (London Heathrow-Mumbai), diverted to Vienna; AI-102 (New York-Delhi), diverted to Sharjah; AI-116 (New York-Mumbai), diverted to Jeddah; AI-2018 (London Heathrow-Delhi), diverted to Mumbai; AI-129 (Mumbai-London Heathrow), returned to Mumbai; AI-119 (Mumbai-New York), returned to Mumbai; AI-103 (Delhi-Washington), returned to Delhi; AI-106 (Newark-Delhi), diverted to Vienna; AI-188 (Vancouver-Delhi), diverted to Jeddah; AI-101 (Delhi-New York), diverted to Frankfurt/Milan; and AI-126 (Chicago-Delhi), diverted to Jeddah. Also impacted were AI-132 (London Heathrow-Bengaluru), diverted to Sharjah; AI-2016 (London Heathrow-Delhi), diverted to Vienna; AI-104 (Washington-Delhi), diverted to Vienna; AI-190 (Toronto-Delhi), diverted to Frankfurt; and AI-189 (Delhi-Toronto), returned to Delhi.

Rs 2,000 denomination fake currency notes dip, but Rs 500 counterfeit notes spike in FY25
Rs 2,000 denomination fake currency notes dip, but Rs 500 counterfeit notes spike in FY25

Time of India

timean hour ago

  • Time of India

Rs 2,000 denomination fake currency notes dip, but Rs 500 counterfeit notes spike in FY25

Chennai: Dip in Rs 2,000 denomination counterfeit notes contributed to the reduction in the value of fake banknotes detected by banks and Reserve Bank, but there was a rise in Rs 500 Fake Indian Currency Notes (FICN) during FY25, RBI data showed. Banknotes of Rs 2,000 denomination were withdrawn from circulation in May 2023, though it continues to be legal tender. The counterfeit notes detected in the denominations of Rs 10, Rs 20, Rs 50, Rs 100 and Rs 2,000 declined in 2024-25, while those in Rs 200 and Rs 500 denominations increased by 13.9% and 37.3%, respectively, when compared with the previous year (FY24). A total number of 2,17,396 FICNs was detected by banks and Reserve Bank in FY25, recording a marginal drop by 2.3% in FY24 at 2,22,639 FICNs. However, it does not include counterfeit notes seized by the police and other enforcement agencies, India's central bank said in its annual report for 2024-25. According to data, Rs 500 FICNs increased from 85,722 in FY24 to 1,17,727 in FY25. Its value rose from around Rs 4.3 crore to Rs 5.9 crore, respectively. Subsequently, the number of Rs 2,000 denomination counterfeit notes plunged by 86.5% YoY at 3,508 in FY25 from 26,035 in FY24. Its value decreased to Rs 70 lakh in FY25 from Rs 5.2 crore in FY24. Further, 32,660 numbers of Rs 200 FICNs and 51,069 in the Rs 100 denomination were detected in the last fiscal (FY25). Out of the total FICNs detected in the banking sector in 2024-25, 95.3% was detected by banks and the rest 4.7% was detected at the Reserve Bank. The report said, a Currency Research and Development Centre (CRDC) has been set up under the administrative control of Bharatiya Reserve Bank Note Mudran (BRBNMPL) for conducting advanced testing of security features of Indian banknotes, counterfeit deterrence tests, forensic/scientific analysis of forged notes, ethical counterfeiting of notes by using latest available tools and technologies and for the development of security/design features for Indian banknotes. Former president of Bank Employees Federation of India C J Nandakumar said, the rise in Rs 500 FICNs indicates the circulation of counterfeit notes. 'Criminals have become sophisticated in designing fake notes with features that even escape from being identified by sorting machines. Apart from issuing guidelines, the regulator must also initiate more stringent actions and supervise to end the menace of FICNs,' he added. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

AstraZeneca Inks China AI Research Deal For Chronic Diseases
AstraZeneca Inks China AI Research Deal For Chronic Diseases

NDTV

time3 hours ago

  • NDTV

AstraZeneca Inks China AI Research Deal For Chronic Diseases

British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC Pharmaceuticals worth up to $5.3 billion to tackle chronic diseases. AstraZeneca, which has a pre-existing collaboration with CSPC, announced earlier this year plans to invest $2.5 billion in China. "This strategic research collaboration underscores our commitment to innovation to tackle chronic diseases which impact over two billion people globally," said AstraZeneca executive vice president Sharon Barr. AstraZeneca aims to develop a research and development centre of up to 1,700 people in the country. CSPC will carry out the research in Shijiazhuang, using "their AI-driven, dual-engine efficient drug discovery platform", the firm said. AstraZeneca said the agreement will see CSPC receive an upfront payment of $110 million, plus up to $1.62 billion in "potential development milestone payments" and up to a further $3.6 billion in sales milestone payments, along with annual sales-based royalties. The multinational will also be able to exercise options for exclusive licences to develop and commercialise worldwide candidates identified under the deal.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store